NEW YORK (GenomeWeb News) —Caprotec Bioanalytics has tapped Funakoshi to market and sell its research products in Japan, the Berlin-based company said today.

Under an exclusive agreement, Funakoshi will distribute Caprotec products based on its Capture Compound Mass Spectrometry technology. The CCMS technology consists of small, tri-functional molecules that are used to isolate proteins from biological samples, which are then identified and characterized by mass spectrometry.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.